Roman Dusil, GM of Pierre Fabre Laboratories in the Czech Republic and Slovakia, shares how the Czech affiliate is ahead of Pierre Fabre’s global transformation of the convergence between the dermo-cosmetic and pharmaceutical verticals. In dermo-cosmetics, Dusil explains the dynamics of the Czech pharmacy market and emphasizes the company’s efforts to catch up with its competitors in the digital space. In pharmaceuticals, the affiliate is gearing up for the launch of Pierre Fabre’s new combo cancer therapy in multiple indications.
Colorectal ... is the second most predominant cancer in the Czech Republic, and an area with a high unmet medical need. Our combo therapy represents a ray of hope for patients
